Crossref
Targeting the TGF-β pathway in patients with non-small cell lung cancer
AME Clinical Trials Review · 2024-10 · 2 · 76-76
DOI: 10.21037/actr-24-80 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024-10. Verfasst von Markus Joerger. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Joerger, M. (2024). Targeting the TGF-β pathway in patients with non-small cell lung cancer. AME Clinical Trials Review, 2, 76-76. https://doi.org/10.21037/actr-24-80
Vancouver
Joerger M. Targeting the TGF-β pathway in patients with non-small cell lung cancer. AME Clinical Trials Review. 2024;2:76-76. doi:10.21037/actr-24-80
BibTeX
@article{Joerger2024,
author = {Joerger, Markus},
title = {Targeting the TGF-β pathway in patients with non-small cell lung cancer},
journal = {AME Clinical Trials Review},
year = {2024},
volume = {2},
pages = {76--76},
doi = {10.21037/actr-24-80}
}
EUVIMED